Utility Study Indicates KidneyIntelX Risk Assessment can Address Treatment Ambiguity in Primary CareGlobeNewsWire • 06/03/21
Atrium Health, Wake Forest Baptist Health, Wake Forest School of Medicine and Renalytix Partner to Advance Kidney HealthGlobeNewsWire • 05/19/21
Kantaro's COVID-SeroKlir Antibody Test Named As A Finalist For Fast Company's 2021 World Changing Ideas AwardsPRNewsWire • 05/04/21
Renalytix AI Stock Jumps After 10-Year US Government Contract For Kidney Disease Testing ServicesBenzinga • 04/22/21
KidneyIntelX Demonstrates Performance and Informs Treatment Decisions in Multinational CANagliflozin CardioVAScular Assessment Study (CANVAS)GlobeNewsWire • 04/20/21
RenalytixAI and Joslin Diabetes Center Build on Proprietary Kidney Biomarker Portfolio for KidneyIntelX PlatformGlobeNewsWire • 04/14/21
Clinical Utility Study Demonstrates Primary Care Physicians Highly Likely to Order KidneyIntelX to Inform Care DecisionsGlobeNewsWire • 04/08/21
Multi-Center Study Finds KidneyIntelX 72% More Effective Than Current Standard of Care In Identifying Early-Stage Patients at High Risk for Kidney Disease Progression and FailureGlobeNewsWire • 04/05/21
Renalytix AI plc Issue of Shares Under the 2020 Employee Share Purchase Plan, PDMR Dealing and Total Voting RightsGlobeNewsWire • 03/04/21
The University of Utah and RenalytixAI Partner to Drive Innovation in Kidney HealthGlobeNewsWire • 02/24/21
RenalytixAI to announce Financial Results for six and three months ended December 31, 2020GlobeNewsWire • 02/23/21
Renalytix Commends HHS/CMS on Finalization of MCIT Rule to Provide National Medicare Coverage for FDA Breakthrough Devices and DiagnosticsGlobeNewsWire • 01/13/21
Early Risk Identification at Core of Innovative Kidney Care Partnership Between Renalytix, DaVitaGlobeNewsWire • 01/05/21